ORIONS Money Stocks

[rru2s]

$TTNP: Selloff overdone yesterday, triggered by Adam Feuerstein twits.

Should get favorable review in tomorrows AdComm FDA meeting. Safety has been established. Effectiveness has been established, meeting usual FDA goals.

An alternative reading of FDA briefing: http://seekingalpha.com/article/1288761-an-alternative-reading-of-fda-briefing-materials-on-titan-s-probuphine

Intradermal efficacy similar to effective oral suboxone for opioid dependency treatment. Greater than 90% of patients finishing treatment said they would want to continue if given the choice. After 24 weeks of treatement, 80% of patients were clean for opioid use over the most recent 2week period. 95% said their lives were improved. Article: http://bit.ly/YEBsZ9